UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HA-1 AND THE SMCY-DERIVED PEPTIDE FIDSYICQV (H-Y) ARE IMMUNODOMINANT MINOR HISTOCOMPATIBILITY ANTIGENS AFTER BONE MARROW TRANSPLANTATION1

Transplantation, 1998-10, Vol.66 (7), p.910-916

1998

Volltextzugriff (PDF)

14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation

Tissue Antigens, 2007-04, Vol.69 (s1), p.17-24

2007

Volltextzugriff (PDF)

In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.966-971

2013

Volltextzugriff (PDF)

Abandoning Care in Laminar Air Flow (LAF) Units and Routine High Dose Intravenous Immunoglobulines (IVIG) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Does Not Increase Mortality and Rate of Infections

Blood, 2004-11, Vol.104 (11), p.5072-5072

2004

Volltextzugriff (PDF)

ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies

Nephrology, dialysis, transplantation, 2009-01, Vol.24 (1), p.298-303

2009

Volltextzugriff (PDF)

Acquired aplastic anaemia: a PNH‐like disease?

British journal of haematology, 1986-10, Vol.64 (2), p.355-362

1986

Volltextzugriff (PDF)

Activity Survey and Historical Perspective of Autologous Stem Cell Transplantation in Europe

Seminars in hematology, 2007-10, Vol.44 (4), p.220-226

Gratwohl, Alois

2007

Volltextzugriff (PDF)

Activity survey and historical perspective of autologous stem cell transplantation in europe: Autologous stem cell transplantation

Seminars in hematology, 2007, Vol.44 (4), p.220-226

GRATWOHL, Alois

2007

Volltextzugriff (PDF)

Adult stem cell transplantation in autoimmune disease

Current opinion in hematology, 2009-07, Vol.16 (4), p.285-291

2009

Volltextzugriff (PDF)

AGRANULOCYTOSIS ASSOCIATED WITH T‐GAMMA‐LYMPHOCYTOSIS: NO IMPROVEMENT OF PERIPHERAL BLOOD GRANULOCYTE COUNT WITH HUMAN‐RECOMBINANT GRANULOCYTE‐MACROPHAGE COLONY‐STIMULATING FACTOR (GM‐CSF)

British journal of haematology, 1989-01, Vol.71 (1), p.157-158

1989

Volltextzugriff (PDF)

The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders

Haematologica (Roma), 2008-12, Vol.93 (12), p.1890-1893

2008

Volltextzugriff (PDF)

Allogeneic Bone Marrow Transplantation in Multiple Myeloma

The New England journal of medicine, 1991-10, Vol.325 (18), p.1267-1273

1991

Volltextzugriff (PDF)

Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation

The New England journal of medicine, 1991-10, Vol.325 (18), p.1267-1273

1991

Volltextzugriff (PDF)

Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy

Brain (London, England : 1878), 2015-10, Vol.138 (Pt 10), p.2847-2858

2015

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Haematologica (Roma), 2006-04, Vol.91 (4), p.513-521

2006

Volltextzugriff (PDF)

Allogeneic hematopoietic stem-cell transplantation for myeloma: it's time for the appropriate studies

Journal of clinical oncology, 2011-06, Vol.29 (16), p.e483; author reply e484-e483

Gratwohl, Alois

2011

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation for severe autoimmune diseases

Autoimmunity (Chur, Switzerland), 2008-01, Vol.41 (8), p.673-678

Gratwohl, Alois

2008

Volltextzugriff (PDF)

Allogeneic Myelo-Ablative Stem Cell Transplant (SCT) as Salvage Therapy of Reduced-Intensity Conditioned (RIC) SCT: Toxicity and Outcome

Blood, 2005-11, Vol.106 (11), p.3666-3666

2005

Volltextzugriff (PDF)

Allogeneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation in the Management of Hematologic Malignancies: An Individual Patient Data Meta-Analysis of Nine Randomized Trials

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5074-5087

Stem Cell Trialists' Collaborative Group

2005

Volltextzugriff (PDF)

1 – 25 von 434

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(391)
Mit Volltextzugriff
(360)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(273)
Humans
(272)
Life Sciences & Biomedicine
(272)
Hematology
(183)
Female
(156)
Biological And Medical Sciences
(155)
Male
(153)
Medical Sciences
(151)
Adult
(149)
Middle Aged
(129)
Adolescent
(94)
Hematologic And Hematopoietic Diseases
(76)
Aged
(67)
Retrospective Studies
(62)
Treatment Outcome
(61)
Child
(60)
Transplantation, Homologous
(59)
Hematopoietic Stem Cell Transplantation
(56)
Transplantation
(53)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(48)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HA-1 AND THE SMCY-DERIVED PEPTIDE FIDSYICQV (H-Y) ARE IMMUNODOMINANT MINOR HISTOCOMPATIBILITY ANTIGENS AFTER BONE MARROW TRANSPLANTATION1

14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation

In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden

Abandoning Care in Laminar Air Flow (LAF) Units and Routine High Dose Intravenous Immunoglobulines (IVIG) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Does Not Increase Mortality and Rate of Infections

ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies

Acquired aplastic anaemia: a PNH‐like disease?

Activity Survey and Historical Perspective of Autologous Stem Cell Transplantation in Europe

Activity survey and historical perspective of autologous stem cell transplantation in europe: Autologous stem cell transplantation

Adult stem cell transplantation in autoimmune disease

AGRANULOCYTOSIS ASSOCIATED WITH T‐GAMMA‐LYMPHOCYTOSIS: NO IMPROVEMENT OF PERIPHERAL BLOOD GRANULOCYTE COUNT WITH HUMAN‐RECOMBINANT GRANULOCYTE‐MACROPHAGE COLONY‐STIMULATING FACTOR (GM‐CSF)

The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders

Allogeneic Bone Marrow Transplantation in Multiple Myeloma

Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation

Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy

Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV

Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Improves Outcome As Compared to Conventional Consolidation in Patients Aged 40–60 Years with AML in CR1 with Apparent Greater Benefit for Reduced Intensity Rather Than Myeloablative Conditioning

Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Allogeneic hematopoietic stem-cell transplantation for myeloma: it's time for the appropriate studies

Allogeneic hematopoietic stem cell transplantation for severe autoimmune diseases

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) - EBMT Risk Score Evaluation for Chronic Myeloid Leukemia in Brazil

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Imatinib-Era: High Survival Rate Following Allogeneic HSCT after Imatinib Failure: Results of the German CML Study IV

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Imatinib-Era: Update on the Survival Outcome Following Allogeneic HSCT after Imatinib Failure; Results of the German CML Study IV

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with a Related Donor in Chronic Myeloid Leukemia (CML): An Explanation for Fast Improvement of Survival in Two Consecutive German CML Studies

Allogeneic Myelo-Ablative Stem Cell Transplant (SCT) as Salvage Therapy of Reduced-Intensity Conditioned (RIC) SCT: Toxicity and Outcome

Allogeneic Peripheral Blood Stem-Cell Compared With Bone Marrow Transplantation in the Management of Hematologic Malignancies: An Individual Patient Data Meta-Analysis of Nine Randomized Trials

Suchergebnisse filtern